Suzhou Mangsha Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Suzhou Mangsha Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CIANLISO. The owner is based in Suzhou City.

Room 306, Building 1, Chuangli Fang Changgu Zhihui Fang

No. 3 Hupai Road, High tech Zone

Suzhou City 215011 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CIANLISO
CIANLISO
Registered 2025

Trademark Classifications

Suzhou Mangsha Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Suzhou Mangsha Technology Co., Ltd have?

Suzhou Mangsha Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Suzhou Mangsha Technology Co., Ltd file in?

Suzhou Mangsha Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Suzhou Mangsha Technology Co., Ltd's most well-known trademarks?

Suzhou Mangsha Technology Co., Ltd's registered trademark portfolio includes well-known marks such as CIANLISO. These are among 1 currently registered trademark in the portfolio.

What is Suzhou Mangsha Technology Co., Ltd's trademark registration success rate?

Suzhou Mangsha Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.